πŸ‡ΊπŸ‡Έ FDA
Patent

US 8003126

Stable tablet formulation

granted A61KA61K31/505A61K9/2018

Quick answer

US patent 8003126 (Stable tablet formulation) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOMARIN PHARMACEUTICAL INC.
Grant date
Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/505, A61K9/2018, A61P, A61P13/02